TrialEuropean heart journal2024

Cardiac biomarkers and effects of aficamten in obstructive hypertrophic cardiomyopathy: the SEQUOIA-HCM trial.

Caroline J Coats et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.